RxDoctor Payments Data

James Voos, MD

Adult Reconstructive Orthopaedic Surgery · Cleveland, OHNPI 1366600561

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 66.6% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $63,789, 2.7 times the $23,654 reported in 2019.

$165,829in general payments, 2019–2025

Across 346 payments — averaging $479.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$111K
  • Medical Device Business Services, Inc.$18K
  • Depuy Synthes Products, Inc.$16K
  • Smith+Nephew$16K
  • Osteocentric Technologies, Inc.$1K
  • Johnson & Johnson$1K
  • plus $3K from 10 others
$101,927in research payments, 2019–2025

Across 4 payments — averaging $25,482 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$73K
  • Arthrex$29K
$1,342in ownership & investment interests, 2019–2025

Across 3 payments — averaging $447.33 each. An ownership or investment interest held by the physician or an immediate family member.

  • Lazurite Inc.$1K

What the payments were for

  • Consulting fees$53,44732%
  • Speaking & faculty fees$85,17551%
  • Travel & lodging$18,61211%
  • Food & beverage$8,5735%
  • Education$210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$165,829 in reported general payments places this provider in the 80th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.

See all adult reconstructive orthopaedic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$3,039
Medicare patients
17
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult reconstructive orthopaedic surgery in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →